{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:37:31Z","timestamp":1783766251699,"version":"3.55.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pcad.2025.08.011","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T06:08:21Z","timestamp":1756706901000},"page":"75-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Emerging tracers for cardiac imaging: Innovations and clinical implications"],"prefix":"10.1016","volume":"93","author":[{"given":"Andrew C.","family":"Homb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apollo W.","family":"Homb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayan","family":"Jouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2025.08.011_bb0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2967\/jnumed.121.263507","article-title":"Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging","volume":"63","author":"Stendahl","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2967\/jnumed.121.263507","article-title":"Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 2: Inflammation, Fibrosis, Thrombosis, Calcification, and Amyloidosis Imaging","volume":"63","author":"Stendahl","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2025.08.011_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002843","article-title":"Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions","volume":"9","author":"Hamo","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"36","key":"10.1016\/j.pcad.2025.08.011_bb0025","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"The 2015 ESC Guidelines for the management of infective endocarditis","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.08.011_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.semnuclmed.2014.06.011","article-title":"Cardiac PET perfusion tracers: current status and future directions","volume":"44","author":"Maddahi","year":"2014","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0035","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2023.08.016","article-title":"Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease","volume":"82","author":"Maddahi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2020.05.063","article-title":"Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease","volume":"76","author":"Maddahi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40119-022-00295-1","article-title":"Emerging PET Tracers in Cardiac Molecular Imaging","volume":"12","author":"Singh","year":"2023","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.pcad.2025.08.011_bb0050","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.2967\/jnumed.122.264867","article-title":"Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy","volume":"64","author":"Bengel","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.yjmcc.2011.07.005","article-title":"PET imaging of cardiac hypoxia: opportunities and challenges","volume":"51","author":"Handley","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-023-09574-4","article-title":"Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers","volume":"16","author":"Shi","year":"2023","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.016323","article-title":"Current and Emerging Radiotracers in Molecular Cardiovascular Imaging","volume":"17","author":"Joshi","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12410-018-9447-3","article-title":"PET Imaging of Cardiac Hypoxia: Hitting Hypoxia Where It Hurts","volume":"11","author":"Pell","year":"2018","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0075","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcmg.2025.03.011","article-title":"Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers","volume":"18","author":"Packard","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11886-020-01284-3","article-title":"Advances in PET-Based Cardiac Amyloid Radiotracers","volume":"22","author":"Gallegos","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102012","article-title":"Novel tracers to assess myocardial inflammation with radionuclide imaging","volume":"42","author":"Lucinian","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11886-017-0843-0","article-title":"Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging","volume":"19","author":"Boutagy","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0095","first-page":"200","article-title":"Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation","volume":"8","author":"Davidson","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11886-023-01869-8","article-title":"The Potential of Fibroblast Activation Protein-Targeted Imaging as a Biomarker of Cardiac Remodeling and Injury","volume":"25","author":"Mayola","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0105","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s12350-018-01484-z","article-title":"Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging","volume":"26","author":"Maddahi","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0110","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2967\/jnumed.111.092528","article-title":"Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest","volume":"52","author":"Maddahi","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0115","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2967\/jnumed.124.268872","article-title":"Biodistribution, Safety Profile, and Radiation Dosimetry of [(18)F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects","volume":"66","author":"Knuuti","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-024-01122-5","article-title":"Preclinical evaluation of [(18)F]SYN1 and [(18)F]SYN2, novel radiotracers for PET myocardial perfusion imaging","volume":"14","author":"Krajewski","year":"2024","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.pcad.2025.08.011_bb0125","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nucmedbio.2015.06.008","article-title":"(18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines","volume":"42","author":"Bartholoma","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41181-022-00171-2","article-title":"Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent","volume":"7","author":"AlHokbany","year":"2022","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.pcad.2025.08.011_bb0135","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41598-022-10004-6","article-title":"PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study","volume":"12","author":"Detmer","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0140","first-page":"66","article-title":"Abstract 251289: Membrane potential imaging with [18F]FTPP+ PET for non-invasive assessment of radiation-induced cardiac lesion","author":"Felicitas Bijari","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcmg.2011.11.017","article-title":"4-[18F]-tetraphenylphosphonium as a PET tracer for myocardial mitochondrial membrane potential","volume":"5","author":"Gurm","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11307-010-0349-2","article-title":"Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium ion. A potential myocardial blood flow agent for PET","volume":"13","author":"Shoup","year":"2011","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.semnuclmed.2020.02.011","article-title":"15O-Water PET MPI: Current Status and Future Perspectives","volume":"50","author":"Maaniitty","year":"2020","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0160","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0165","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pcad.2025.08.011_bb0170","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12350-019-01782-0","article-title":"Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study","volume":"28","author":"Bravo","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s12350-023-03219-1","article-title":"Reference myocardial uptake values on somatostatin receptor-targeted PET: not yet in preference to visual assessment","volume":"30","author":"Lee","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0180","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of Atherosclerotic Inflammation by (68)Ga-DOTATATE PET Compared to [(18)F]FDG PET Imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT - A comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jacc.2022.10.034","article-title":"Somatostatin Receptor PET\/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis","volume":"81","author":"Corovic","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0195","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2967\/jnumed.124.267948","article-title":"Cardiac Neuroendocrine Tumor Metastases on (68)Ga-DOTATATE PET\/CT: Identification and Prognostic Significance","volume":"65","author":"Lee","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13550-020-00742-x","article-title":"FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET","volume":"10","author":"Martineau","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.pcad.2025.08.011_bb0205","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG\/Perfusion-PET: A Prospective Pilot Study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.pcad.2025.08.011_bb0215","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"(18)F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0220","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s12350-020-02262-6","article-title":"Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel (68)Ga-mCXCL12 PET tracer","volume":"28","author":"Zacherl","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0225","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","article-title":"Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction","volume":"8","author":"Thackeray","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0230","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jcmg.2018.01.001","article-title":"Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [(68)Ga]Pentixafor-PET\/CT in Correlation With Cardiac MRI","volume":"11","author":"Reiter","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jcmg.2021.08.013","article-title":"CXCR4-Targeted Imaging of Post-Infarct Myocardial Tissue Inflammation: Prognostic Value After Reperfused Myocardial Infarction","volume":"15","author":"Werner","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0240","first-page":"10","article-title":"[(68)Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with (18)F[FDG] PET Imaging","author":"Lawal","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.pcad.2025.08.011_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.semnuclmed.2023.09.002","article-title":"Advances in PET Imaging of the CXCR4 Receptor: [(68)Ga]Ga-PentixaFor","volume":"54","author":"Lindenberg","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0250","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.117.196485","article-title":"Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using (68)Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden","volume":"59","author":"Weiberg","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0255","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00259-017-3831-0","article-title":"[68Ga]Pentixafor-PET\/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques","volume":"45","author":"Li","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0260","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00259-019-04322-7","article-title":"[(68)Ga]Pentixafor PET\/MR imaging of chemokine receptor 4 expression in the human carotid artery","volume":"46","author":"Li","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0265","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009889","article-title":"CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction","volume":"13","author":"English","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2967\/jnumed.120.244673","article-title":"Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart","volume":"62","author":"Heo","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.nucmedbio.2024.108893","article-title":"Development of a CCR2 targeted (18)F-labeled radiotracer for atherosclerosis imaging with PET","volume":"130-131","author":"Zhang","year":"2024","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-025-01254-2","article-title":"Macrophage mannose receptor CD206-targeted PET imaging in experimental acute myocardial infarction","volume":"15","author":"Andriana","year":"2025","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.pcad.2025.08.011_bb0285","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nm.3437","article-title":"2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis","volume":"20","author":"Tahara","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0290","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","article-title":"Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein","volume":"57","author":"Fan","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0295","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2967\/jnumed.120.243600","article-title":"Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with (18)F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism","volume":"62","author":"MacAskill","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2967\/jnumed.110.079038","article-title":"Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET\/CT","volume":"52","author":"Lamare","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0305","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/eurheartj\/ehr367","article-title":"Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography\/computed tomography","volume":"33","author":"Gaemperli","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.08.011_bb0310","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2010.02.063","article-title":"Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography\/computed tomography angiography","volume":"56","author":"Pugliese","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.12997\/jla.2020.9.3.349","article-title":"An Update on [(18)F]Fluoride PET Imaging for Atherosclerotic Disease","volume":"9","author":"Lee","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.pcad.2025.08.011_bb0320","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/ATVBAHA.120.313785","article-title":"(18)F-Sodium Fluoride ((18)F-NaF) for Imaging Microcalcification Activity in the Cardiovascular System","volume":"40","author":"Tzolos","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0325","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","article-title":"Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology","volume":"59","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0330","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ehjci\/jez152","article-title":"Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography","volume":"21","author":"Kwiecinski","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0335","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamacardio.2023.1729","article-title":"Coronary Atherosclerotic Plaque Activity and Future Coronary Events","volume":"8","author":"Moss","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis","volume":"125","author":"Dweck","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2025.08.011_bb0345","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2018.12.056","article-title":"Detection and Prediction of Bioprosthetic Aortic Valve Degeneration","volume":"73","author":"Cartlidge","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0350","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s12350-020-02307-w","article-title":"Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling","volume":"28","author":"Siebermair","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0355","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0360","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a (68)Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04","volume":"60","author":"Varasteh","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0365","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2967\/jnumed.122.265147","article-title":"Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study","volume":"64","author":"Diekmann","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0370","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jcmg.2022.06.004","article-title":"Feasibility of (68)Ga-Labeled Fibroblast Activation Protein Inhibitor PET\/CT in Light-Chain Cardiac Amyloidosis","volume":"15","author":"Wang","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0375","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010628","article-title":"Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease","volume":"13","author":"Heckmann","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0380","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/ehjci\/jeab053","article-title":"Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI)","volume":"22","author":"Almeida","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0385","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11886-022-01641-4","article-title":"PET Tracers for Imaging Cardiac Function in Cardio-oncology","volume":"24","author":"Kelly","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0390","first-page":"1957","article-title":"Relationship Between Myocardial Clearance Rates of Carbon 11-Acetate-Derived Radiolabel and Oxidative Metabolism: Physiologic Basis and Clinical Significance","volume":"32","author":"Lear","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0395","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.nuclcard.2007.02.007","article-title":"Imaging of myocardial fatty acid metabolism with PET","volume":"14","author":"Bergmann","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0400","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.nucmedbio.2014.08.006","article-title":"[(11)C]-Acetoacetate PET imaging: a potential early marker for cardiac heart failure","volume":"41","author":"Croteau","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11307-024-01978-y","article-title":"2-[(18)F]Fluoropropionic Acid PET Imaging of Doxorubicin-Induced Cardiotoxicity","volume":"27","author":"Azcona","year":"2025","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0410","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12967-018-1670-9","article-title":"An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline","volume":"16","author":"Sarocchi","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0415","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2013.07.021","article-title":"Cardiac (1)(8)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy","volume":"109","author":"Evans","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0420","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2967\/jnumed.119.226787","article-title":"Imaging of Chemotherapy-Induced Acute Cardiotoxicity with (18)F-Labeled Lipophilic Cations","volume":"60","author":"McCluskey","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215579","article-title":"68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity","volume":"14","author":"Sivapackiam","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.pcad.2025.08.011_bb0430","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11886-020-01315-z","article-title":"PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity","volume":"22","author":"Sivapackiam","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0435","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0440","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jcmg.2020.09.026","article-title":"Regional Distribution of Fluorine-18-Flubrobenguane and Carbon-11-Hydroxyephedrine for Cardiac PET Imaging of Sympathetic Innervation","volume":"14","author":"Zelt","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0445","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0450","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s12350-021-02813-5","article-title":"F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation","volume":"29","author":"Grkovski","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0455","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s12350-022-03150-x","article-title":"Imaging of cardiac sympathetic dysfunction with 18F-FDOPA PET\/CT in patients with heart failure: a pilot study","volume":"30","author":"Thanigainathan","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0460","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-004-1701-z","article-title":"Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388","volume":"32","author":"de Jong","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040629","article-title":"Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide (124)I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET\/CT Imaging","volume":"16","author":"Martin","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pcad.2025.08.011_bb0470","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcmg.2025.01.018","article-title":"Early Detection of Transthyretin Cardiac Amyloidosis Using (124)I-Evuzamitide Positron Emission Tomography\/Computed Tomography","volume":"18","author":"Smiley","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0475","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11307-021-01681-2","article-title":"First in Human Evaluation and Dosimetry Calculations for Peptide (124)I-p5+14-a Novel Radiotracer for the Detection of Systemic Amyloidosis Using PET\/CT Imaging","volume":"24","author":"Wall","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0480","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac Amyloid Detection by PET\/CT Imaging of Iodine ((124)I) Evuzamitide ((124)I-p5+14): A Phase 1\/2 Study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0485","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12350-020-02363-2","article-title":"(18)F-flutemetamol positron emission tomography in cardiac amyloidosis","volume":"29","author":"Papathanasiou","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0490","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12350-016-0638-5","article-title":"Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)","volume":"25","author":"Pilebro","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0495","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11886-022-01811-4","article-title":"Radiolabeled Thioflavin-T Derivative PET Imaging for the Assessment of Cardiac Amyloidosis","volume":"24","author":"Boczar","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.pcad.2025.08.011_bb0500","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0505","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0510","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","article-title":"Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body (18)F-Florbetapir PET\/CT","volume":"60","author":"Ehman","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0515","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0520","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jcmg.2022.10.002","article-title":"Noninvasive In Vivo Coronary Artery Thrombus Imaging","volume":"16","author":"Tzolos","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0525","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2967\/jnumed.118.212084","article-title":"Glycoprotein IIb\/IIIa receptor imaging with (18)F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study","volume":"60","author":"Kim","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13550-018-0471-8","article-title":"A phase 1, first-in-human study of (18)F-GP1 positron emission tomography for imaging acute arterial thrombosis","volume":"9","author":"Chae","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.pcad.2025.08.011_bb0535","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcmg.2021.08.009","article-title":"Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance","volume":"15","author":"Izquierdo-Garcia","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0540","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11307-024-01973-3","article-title":"First-in-human Evaluation of Safety and Dosimetry of [(64)Cu]FBP8: A fibrin-binding PET Probe","volume":"27","author":"Izquierdo-Garcia","year":"2025","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0545","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1136\/heartjnl-2019-315487","article-title":"Imaging at the inter-face of inflammation and angiogenesis by (18)F-fluciclatide PET","volume":"105","author":"Tarkin","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2025.08.011_bb0550","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s12350-023-03265-9","article-title":"[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure","volume":"30","author":"Bentsen","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0555","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/heartjnl-2016-310115","article-title":"Cardiac \u03b1\u03b2 integrin expression following acute myocardial infarction in humans","volume":"103","author":"Jenkins","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2025.08.011_bb0560","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07489-4","article-title":"[(68)Ga]Ga-NODAGA-RGD post MI reflects activated fibroblasts rather than angiogenesis","author":"Raitza","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0565","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s12350-023-03347-8","article-title":"Targeted imaging of angiogenesis post-myocardial infarction predicts development of heart failure","volume":"30","author":"Sinusas","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0570","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jcmg.2014.12.015","article-title":"In Vivo Imaging of Hypoxia in Atherosclerotic Plaques in Humans","volume":"8","author":"van der Valk","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009791","article-title":"(64)Cu-ATSM Positron Emission Tomography\/Magnetic Resonance Imaging of Hypoxia in Human Atherosclerosis","volume":"13","author":"Nie","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.08.011_bb0580","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s11307-022-01718-0","article-title":"Detection of cardiac apoptosis by [(18)F]ML-10 in a mouse model of permanent LAD ligation","volume":"24","author":"Fischer","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pcad.2025.08.011_bb0585","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12149-022-01801-0","article-title":"Detection of apoptosis by [(18)F]ML-10 after cardiac ischemia-reperfusion injury in mice","volume":"37","author":"Fischer","year":"2023","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0590","first-page":"14","article-title":"Artificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and Recent Clinical Trials","author":"Golub","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0595","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnumed.119.226498","article-title":"First Human Imaging Studies with the EXPLORER Total-Body PET Scanner","volume":"60","author":"Badawi","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.08.011_bb0600","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:08:33Z","timestamp":1765775313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062025001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":120,"alternative-id":["S0033062025001331"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2025.08.011","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging tracers for cardiac imaging: Innovations and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2025.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}